Challenges of persons with multiple sclerosis on ocrelizumab treatment during COVID-19 pandemic

Baba C., Yigit P., Dastan S., Hancer P., Sagici O., ÖZAKBAŞ S., ...Daha Fazla

NEUROLOGY AND CLINICAL NEUROSCIENCE, cilt.10, sa.1, ss.3-8, 2022 (ESCI, Scopus) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 10 Sayı: 1
  • Basım Tarihi: 2022
  • Doi Numarası: 10.1111/ncn3.12561
  • Dergi Adı: NEUROLOGY AND CLINICAL NEUROSCIENCE
  • Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), Scopus
  • Sayfa Sayıları: ss.3-8
  • Anahtar Kelimeler: COVID-19, multiple sclerosis, ocrelizumab, pandemic
  • Dokuz Eylül Üniversitesi Adresli: Evet

Özet

Background: Coronavirus disease of the 2019 pandemic caused much fear among people with chronic diseases and those on immunosuppressant treatment because of spreading knowledge that the infection has a fatal course in these populations. People with Multiple Sclerosis on ocrelizumab treatment share this fear too. We aimed to investigate treatment and lifestyle changes of people with multiple sclerosis on ocrelizumab treatment during the lockdown.